Trade Summary

2 days ago, Girao Tiago, serving as Chief Financial Officer at Immunovant, Inc. (IMVT), sold 10,000 shares at $38.46 per share, for a total transaction value of $384,600.00. Following this transaction, Girao Tiago now holds 247,596 shares of IMVT.

This sale represents a 3.88% decrease in Girao Tiago's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 7:44 PM ET, meaning the disclosure happened on the same day as the trade.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.